Regulatory Exclusivity. On a Royalty Bearing Product-by-Royalty Bearing Product basis, if the sole basis for the continuance of a Royalty Term is the existence of Regulatory Exclusivity, the applicable royalty under Section 5.2 and/or Section 5.3 shall be reduced by fifty percent (50%).
Appears in 2 contracts
Sources: Strategic Alliance Agreement, Strategic Alliance Agreement (Infinity Pharmaceuticals, Inc.)
Regulatory Exclusivity. On a Royalty Bearing Product-by-Royalty Bearing Product and country-by-country basis, if the sole basis for the continuance of a Royalty Term is the existence of Regulatory Exclusivity, the applicable royalty under Section 5.2 and/or Section 5.3 shall be reduced by fifty percent (50%).
Appears in 1 contract
Sources: Strategic Alliance Agreement (Infinity Pharmaceuticals, Inc.)